4.6 Article

Genetic Variations in GRIA1 on Chromosome 5q33 Related to Asparaginase Hypersensitivity

期刊

CLINICAL PHARMACOLOGY & THERAPEUTICS
卷 88, 期 2, 页码 191-196

出版社

WILEY
DOI: 10.1038/clpt.2010.94

关键词

-

资金

  1. National Cancer Institute [CA 21765]
  2. NIH/NIGMS Pharmacogenetics Research Network and Database [U01 GM61393, U01GM61374]
  3. American Lebanese Syrian Associated Charities

向作者/读者索取更多资源

The genetic variations that result in allergy to asparaginase are as yet undetermined. We interrogated more than 500,000 single-nucleotide polymorphisms (SNPs) in 485 children with acute lymphoblastic leukemia (ALL), 322 in a discovery cohort, and 163 in a validation cohort. In the top 100 SNPs associated with allergy in the discovery cohort, chromosome 5 was overrepresented as compared with other chromosomes (P = 0.00032), hosting 10 SNPs annotated to genes. Among these 10 SNPs, one SNP (rs4958381), in GRIA1 on chromosome 5q33, was replicated in the validation cohort (P = 1.8 x 10(-5), 2.9 x 10(-3), and 3.5 x 10(-7) in the discovery, validation, and combined cohorts, respectively). Four additional SNPs annotated to GRIA1 were also significantly associated with allergy (P < 0.05) in both cohorts. Chromosome 5q33 has previously been associated with asthma and atopy. These data contribute to the growing body of evidence that there is an inherited component to predisposition to drug allergy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据